Advertisement

Topics

Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol

2017-08-10 15:08:21 | BioPortfolio

Summary

To research the effect of propranolol on the proliferation and apoptosis of gastrointestinal cancer.

Study Design

Conditions

Gastrointestinal Cancer

Intervention

Propranolol

Location

Institute of Clinical Pharmacology
Changsha
Hunan
China
410005

Status

Not yet recruiting

Source

Central South University

Results (where available)

View Results

Links

Published on BioPortfolio: 2017-08-10T15:08:21-0400

Clinical Trials [634 Associated Clinical Trials listed on BioPortfolio]

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

This study is being conducted in patients with newly diagnosed breast cancer that will be undergoing chemotherapy prior to surgery - neoadjuvant chemotherapy. The study involves treatment ...

Propranolol Dose Escalation in Lymphedema in Patients

This is a study to investigate the safety and efficacy of propranolol in the treatment of patients with primary lymphedema. The primary goal is to assess patient tolerability of increasing...

Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia

This is a randomized, double-blind, multi-centered study to compare 6 months of medical treatment with digoxin or propranolol in infants with SVT Background: SVT is the most common sustain...

MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients

The effectiveness of propranolol in infantile hemangiomas, the apparent better response to propranolol in breast cancer and the use of propranolol in a proportion of patients who did not d...

Propranolol for Treating Fibromyalgia Pain

The purpose of the study to evaluate the feasibility of using low dose propranolol for people with fibromyalgia.

PubMed Articles [14590 Associated PubMed Articles listed on BioPortfolio]

Anti-tumor effects of propranolol: Adjuvant activity on a transplanted murine breast cancer model.

Propranolol (Pro), a non-specific β-adrenergic blocking drug, competitively prevents the binding of catecholamines to receptors and suppresses cancer cells. The anti-tumor activity of propranolol has...

Quantifying the effects of aging and urbanization on major gastrointestinal diseases to guide preventative strategies.

This study aimed to quantify the effects of aging and urbanization on major gastrointestinal disease (liver cirrhosis, hepatitis B, diarrhea, liver cancer, stomach cancer, pancreas cancer, hepatitis C...

Exploring the microbiota to better understand gastrointestinal cancers physiology.

Gastrointestinal cancers account for around 40% of cancer-related deaths worldwide, representing a global health burden. There is a growing body of evidence highlighting the link between microbiota an...

Methods and approaches for determination and enantioseparation of (RS)-propranolol.

Propranolol, a β-adrenergic receptor antagonist, is a chiral compound which is marketed as a racemate, but only (S)-(-)-enantiomer is responsible for the β-adrenoceptor blocking activity. Different ...

High Expression of PLOD1 Drives Tumorigenesis and Affects Clinical Outcome in Gastrointestinal Carcinoma.

PLOD1 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1) is important for extracellular matrix formation and is involved in various diseases, including cancer; however, its role in gastrointestinal ...

Medical and Biotech [MESH] Definitions

A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.

Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.

A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)

Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.

A cardioselective beta-adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.

More From BioPortfolio on "Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Searches Linking to this Trial